BSX
Boston Scientific Corporation β’ Healthcare (#5 of 11)
$62.00
-0.75 (-1.20%)
View:
Close:$62.00
Vol:HIGH(85%ile)
Ratio:1.04x
|RSI:24(Oversold)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ1 Down8 Hold
Mar 30RBC Capital
βOutperform
Mar 30Raymond James
βΌStrong Buy β Outperform
Mar 30Needham
βBuy
Mar 27Goldman Sachs
βBuy
Mar 20Stifel
βBuy
Mar 20Needham
βBuy
Mar 18Truist Securities
βBuy
Mar 17UBS
βBuy
Mar 11Citigroup
βBuy
Price Targets
(60d mean: $102, +65.0%)β²0 RaisesβΌ6 Lowers
Mar 30RBC Capital
$115β$115New
Mar 30Raymond James
$97β$88-9.3%
Mar 30Needham
$97β$97New
Mar 27Goldman Sachs
$98β$93-5.1%
Mar 20Stifel
$110β$90-18.2%
Mar 20Needham
$97β$97New
Mar 18Truist Securities
$95β$92-3.2%
Mar 17UBS
$120β$105-12.5%
Mar 11Citigroup
$102β$94-7.8%
Trade Setup
Entry$62.00
Target$66.77 (+7.7%)
Stop$57.23
R/R1.00
Risk-7.7%
Conv17 (LOW)
Size92 shares ($5,704)
Risk Metrics
Sharpe (20d)
-4.80Losing
Volatility (20d)
38.3%Normal
Beta (60d)
0.00Defensive
Alpha (20d)
-9.9%Weak
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.